1-3 of 3
Linda Curtis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estrogen Receptor-α Phosphorylated at Ser118 Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression

Gregory E. Weitsman, Lin Li, George P. Skliris, James R. Davie, Kanyarat Ung, Yulian Niu, Linda Curtis-Snell, Ladislav Tomes, Peter H. Watson, Leigh C. Murphy
Journal: Cancer Research
Cancer Res (2006) 66 (20): 10162–10170.
https://doi.org/10.1158/0008-5472.CAN-05-4111
Published: 17 October 2006
View article titled, Estrogen Receptor-α Phosphorylated at Ser<sup>118</sup> Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression
Open the PDF for Estrogen Receptor-α Phosphorylated at Ser<sup>118</sup> Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression in another window
Journal Articles

The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer

Ethan D. Emberley, Yulian Niu, Linda Curtis, Sandra Troup, Sanat K. Mandal, Jeffery N. Myers, Spencer B. Gibson, Leigh C. Murphy, Peter H. Watson
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5696–5702.
https://doi.org/10.1158/0008-5472.CAN-04-3927
Published: 01 July 2005
View article titled, The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer
Open the PDF for The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer in another window
Journal Articles

Psoriasin (S100A7) stimulates pro-survival pathways through activation of Jab1 in breast cancer

Ethan D. Emberley, Linda Curtis, Jeffery N. Myers, Leigh C. Murphy, Peter H. Watson
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 952.
Published: 01 April 2004
View article titled, Psoriasin (S100A7) stimulates pro-survival pathways through activation of Jab1 in breast cancer